[HTML][HTML] Pharmacological treatments of COVID-19

A Sahebnasagh, R Avan, F Saghafi… - Pharmacological …, 2020 - Springer
A Sahebnasagh, R Avan, F Saghafi, M Mojtahedzadeh, A Sadremomtaz, O Arasteh
Pharmacological Reports, 2020Springer
The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19),
which was reported for the first time in December 2019, was named by the World Health
Organization (WHO) as Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV2),
because of the very similar genome and also its related symptoms to SARS-CoV1. The
ongoing COVID-19 pandemic with significant mortality, morbidity, and socioeconomic impact
is considered by the WHO as a global public health emergency. Since there is no specific …
Abstract
The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19), which was reported for the first time in December 2019, was named by the World Health Organization (WHO) as Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV2), because of the very similar genome and also its related symptoms to SARS-CoV1. The ongoing COVID-19 pandemic with significant mortality, morbidity, and socioeconomic impact is considered by the WHO as a global public health emergency. Since there is no specific treatment available for SARS-CoV2 infection, and or COVID-19, several clinical and sub-clinical studies are currently undertaken to find a gold-standard therapeutic regimen with high efficacy and low side effect. Based on the published scientific evidence published to date, we summarized herein the effects of different potential therapies and up-to-date clinical trials. The review is intended to help readers aware of potentially effective COVID-19 treatment and provide useful references for future studies.
Springer
以上显示的是最相近的搜索结果。 查看全部搜索结果